Whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention after pretreatment with clopidogrel is unknown. The incidence of ...

Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a control group consisting of drug-eluting stent (DES) and balloon angioplasty (BA ...

Dr. Richard Nesto answers the question: 'Percutaneous Coronary Intervention?' — -- Question: What does percutaneous coronary intervention (PCI) mean and when is it done? Answer: Percutaneous ...

Age-related physiological changes augment both the potential benefit of coronary revascularization and the risk of procedure-related adverse outcomes A broad range of antithrombin and antiplatelet ...

Please provide your email address to receive an email when new articles are posted on . Despite similar procedural success, percutaneous mitral valve repair for post-MI mitral regurgitation was ...

The literature examining the utility of beta blockers in the setting of acute coronary syndrome (ACS) to limit infarct size has produced conflicting results within and across treatment eras. Animal ...

Primary percutaneous coronary intervention, where available, has become the therapy of choice in myocardial reperfusion during ST-elevation myocardial infarction. However, in a significant proportion ...

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A ...

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery ...

There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes. However, a new study reveals that the ...